Impact of the new European Union In Vitro Diagnostics Regulation on the practice of hospital diagnostic laboratories
Open Access
- 4 May 2022
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 22 (5) , 583-590
Abstract
The In Vitro Diagnostics Regulation 2017/746 (IVDR) coming into force from May 2022, creates the first European regulatory recognition for biomarker tests linked to medicinal products, so-called co...Keywords
This publication has 17 references indexed in Scilit:
- All aboard: Will molecular tumor boards help cancer patients?Nature Medicine, 2015
- Home-brew tests need regulationNature, 2014
- Developing a framework for implementation of genetic services: learning from examples of testing for monogenic forms of common diseasesJournal of Community Genetics, 2014
- Cancer Drug Development and the Evolving Regulatory Framework for Companion Diagnostics in the European UnionClinical Cancer Research, 2014
- Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in actionCancer Treatment Reviews, 2013
- Innovation in healthcare: Issues and future trendsJournal of Business Research, 2012
- Variability in the use of CE-marked assays for in vitro diagnostics of CFTR gene mutations in European genetic testing laboratoriesEuropean Journal of Human Genetics, 2008
- Two traditions of interaction researchBritish Journal of Social Psychology, 2004
- Validity in Qualitative ResearchQualitative Health Research, 2001
- ORGANIZATIONAL ASSIMILATION OF INNOVATIONS: A MULTILEVEL CONTEXTUAL ANALYSIS.Academy of Management Journal, 1988